Drug Co. Peloton Snags $150M In Funding For Cancer Trials
Biopharmaceutical firm Peloton Therapeutics Inc. on Wednesday said its latest funding round brought in $150 million from a swath of new and existing investors as the company looks to advance the...To view the full article, register now.
Already a subscriber? Click here to view full article